{"database": "lobbying", "table": "lobbying_activities", "rows": [[1554004, "9066f758-044f-4e67-b60d-40140c585571", "Q2", "VENABLE LLP", 39941, "ENDO PHARMACEUTICALS INC", 2014, "second_quarter", "PHA", "Issues related to bioequivalence and related administrative procedures; issues related to prescription drug abuse; issues related to the labeling of generic drugs; issues related to tamper resistant formulation of pharmaceutical drugs. The Life Sciences Jobs and Investment Act; Issues relating to Medicare Part D rebates; H.R. 486  Stop Tampering of Prescription Pills Act of 2013; H.R. 1919  Safeguarding Americas Pharmaceuticals Act of 2013", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2014-07-16T18:13:49.103000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1554004"], "units": {}, "query_ms": 5.001968005672097, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}